PROSPERI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 20.496
EU - Europa 10.975
AS - Asia 3.881
SA - Sud America 343
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 11
Totale 35.767
Nazione #
US - Stati Uniti d'America 20.107
IT - Italia 2.988
DE - Germania 2.434
SG - Singapore 1.469
CN - Cina 1.068
SE - Svezia 998
DK - Danimarca 909
IE - Irlanda 880
RU - Federazione Russa 669
UA - Ucraina 503
GB - Regno Unito 448
HK - Hong Kong 398
VN - Vietnam 367
CA - Canada 362
BR - Brasile 297
PL - Polonia 289
FR - Francia 230
AT - Austria 196
IN - India 174
FI - Finlandia 168
ID - Indonesia 111
TR - Turchia 67
NL - Olanda 63
KR - Corea 54
IR - Iran 36
BE - Belgio 35
CH - Svizzera 32
CZ - Repubblica Ceca 29
ES - Italia 20
JP - Giappone 20
MX - Messico 18
EU - Europa 17
AR - Argentina 15
IL - Israele 15
GR - Grecia 14
AZ - Azerbaigian 10
BD - Bangladesh 10
RO - Romania 10
UZ - Uzbekistan 9
MU - Mauritius 8
PH - Filippine 8
PT - Portogallo 8
AU - Australia 7
HU - Ungheria 7
IQ - Iraq 7
KE - Kenya 7
NO - Norvegia 7
TW - Taiwan 7
CO - Colombia 6
LT - Lituania 6
MA - Marocco 6
PE - Perù 6
SA - Arabia Saudita 6
SC - Seychelles 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
CL - Cile 5
EG - Egitto 5
LU - Lussemburgo 5
MD - Moldavia 5
MO - Macao, regione amministrativa speciale della Cina 5
PK - Pakistan 5
EC - Ecuador 4
KG - Kirghizistan 4
LK - Sri Lanka 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
AL - Albania 3
DO - Repubblica Dominicana 3
LB - Libano 3
PA - Panama 3
PY - Paraguay 3
AM - Armenia 2
CI - Costa d'Avorio 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
MY - Malesia 2
NG - Nigeria 2
OM - Oman 2
TH - Thailandia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
IM - Isola di Man 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MK - Macedonia 1
ML - Mali 1
NP - Nepal 1
QA - Qatar 1
Totale 35.762
Città #
Ann Arbor 7.834
Frankfurt am Main 2.157
Woodbridge 1.586
Fairfield 1.435
Chandler 1.081
Milan 1.051
Houston 1.004
Singapore 920
Dublin 849
Wilmington 830
Ashburn 740
Jacksonville 541
Seattle 538
Dearborn 514
Cambridge 483
Santa Clara 415
Hong Kong 391
New York 353
Princeton 290
Kraków 264
Nanjing 189
Dong Ket 185
Vienna 182
Shanghai 177
Lawrence 144
Altamura 136
Toronto 116
Jakarta 102
Council Bluffs 97
Guangzhou 95
San Diego 86
Fremont 85
Lachine 85
Beijing 77
Montréal 77
Helsinki 68
Nanchang 57
Los Angeles 51
Ottawa 50
London 48
Florence 47
Shenyang 46
Rome 45
Pavia 43
Moscow 39
Tianjin 39
Boardman 36
Changsha 36
Hebei 34
Brooklyn 33
Brussels 30
Monza 30
Palermo 28
Pune 28
Old Bridge 27
Jinan 26
Kunming 26
Nuremberg 26
Turin 26
Como 25
Jiaxing 25
Sacramento 25
São Paulo 25
Andover 24
Hyderabad 24
Chicago 22
Edmonton 21
Falls Church 21
Norwalk 21
Hangzhou 20
Livorno 20
Sarno 20
Mountain View 19
Munich 19
Bologna 18
Sesto San Giovanni 18
Verona 18
Bergamo 17
Grafing 17
Kiev 16
Ningbo 16
Slavonice 16
Zhengzhou 16
Vercelli 15
Dallas 14
Brescia 13
Kocaeli 13
Leawood 13
Melzo 13
Napoli 13
Warsaw 13
Cinisello Balsamo 12
Hefei 12
Monmouth Junction 12
Torino 12
Carate Brianza 11
Desio 11
Huizen 11
Mumbai 11
Naples 11
Totale 26.721
Nome #
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies 507
MnO Nanoparticles Embedded in Functional Polymers as T1 Contrast Agents for Magnetic Resonance Imaging 504
Uniform Lipopolysaccharide (LPS)-Loaded Magnetic Nanoparticles for the Investigation of LPS–TLR4 Signaling 479
Engineered Ferritin Nanoparticles for the Bioluminescence Tracking of Nanodrug Delivery in Cancer 469
Thirty years of cancer nanomedicine: Success, frustration, and hope 468
Multifunctional Magnetic Gold Nanomaterials for Cancer 465
Modeling the interaction of amphiphilic polymer nanoparticles with biomembranes to Guide rational design of drug delivery systems 458
Inositol 1,4,5-trisphosphate 3-kinase B promotes Ca2+mobilization and the inflammatory activity of dendritic cells 454
Targeted delivery of nanoparticles 438
The emerging role of nanotechnology in skincare 438
Are nanotechnological approaches the future of treating inflammatory diseases? 437
Colloidal polymer-coated Zn-doped iron oxide nanoparticles with high relaxivity and specific absorption rate for efficient magnetic resonance imaging and magnetic hyperthermia 429
Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells 427
Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax 418
Functionalization of colloidal nanoparticles with a discrete number of ligands based on a “HALO-bioclick” reaction 414
Negatively charged silver nanoparticles with potent antibacterial activity and reduced toxicity for pharmaceutical preparations 412
Relaxometric studies of Gd-Chelate conjugated on the surface of differently shaped gold nanoparticles 400
99mTc-radiolabeled silica nanocarriers for targeted detection and treatment of HER2-positive breast cancer 391
Development of99mtc-radiolabeled nanosilica for targeted detection of HER2-positive breast cancer 387
Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome 384
Nanoparticle-Mediated Suicide Gene Therapy for Triple Negative Breast Cancer Treatment 381
H-Ferritin Enriches the Curcumin Uptake and Improves the Therapeutic Efficacy in Triple Negative Breast Cancer Cells 376
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 376
Monitoring the fate of orally administered plga nanoformulation for local delivery of therapeutic drugs 369
Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles 367
Dynamic molecular exchange and conformational transitions of alpha-synuclein at the nano-bio interface 364
Cetuximab-conjugates nanoparticles for the treatment of triple negative breast cancer 356
Evaluation of tfr-1 expression in feline mammary cancer and in vitro antitumor efficacy study of doxorubicin-loaded h-ferritin nanocages 335
A fast and straightforward procedure for vault nanoparticle purification and the characterization of its endocytic uptake 319
Bioengineered Approaches for Site Orientation of Peptide-Based Ligands of Nanomaterials 319
Preface frontiers in cancer immunotherapy: Understanding the role of gut microbiota 314
Half-Chain Cetuximab Nanoconjugates Allow Multitarget Therapy of Triple Negative Breast Cancer 313
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study 313
Half-Chain trastuzumab nanoconjugates enhance antitumor activity in HER2+ breast cancer 313
Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies 310
Metronomic nanocaged doxorubicin prevents chemoresistance and cardiotoxicity in breast cancer 304
Suicide gene therapy: A new frontier for cancer fighting 301
Recent advances in magnetic fluid hyperthermia for cancer therapy 299
Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model 299
Anti-madcam-1-conjugated nanocarriers delivering quantum dots enable specific imaging of inflammatory bowel disease 298
Theranostic Nanocages for Imaging and Photothermal Therapy of Prostate Cancer Cells by Active Targeting of Neuropeptide-Y Receptor 297
“Blind” targeting in action: From phage display to breast cancer cell targeting with peptide-gold nanoconjugates 287
Curcumin Formulations and Trials: What’s New in Neurological Diseases 286
Olaparib nanoformulation in H-Ferritin for the triple negative breast cancer treatment 275
Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity 269
Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity 269
Specific immunosuppressive role of nanodrugs targeting calcineurin in innate myeloid cells 267
Conformational properties of intrinsically disordered proteins bound to the surface of silica nanoparticles 261
Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice 261
MAdCAM-1 nanotargeting uncovers bowel inflammation foci in experimental model of colitis 261
Meet our editor-in-chief 259
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages 257
Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells 253
Loss of exosomes in progranulin-associated frontotemporal dementia 251
Detection of nanostructures in solutions of Zincum metallicum and the vehicle lactose 249
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents 247
Combined mass quantitation and phenotyping of intact extracellular vesicles by a microarray platform 235
Nano-targeting of Mucosal Addressin Cell Adhesion Molecule-1 identifies bowel inflammation foci in murine model 235
Dependence of nanoparticle-cell recognition efficiency from surface orientation of scFv targeting ligands 233
HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches 230
Delivering colloidal nanoparticles to mammalian cells: a nano-bio interface perspective 225
Nanoparticle-mediated delivery of suicide genes in cancer therapy 225
H-Ferritin-nanocaged olaparib: A promising choice for both BRCA-mutated and sporadic triple negative breast cancer 220
Development of an Effective Tumor-Targeted Contrast Agent for Magnetic Resonance Imaging Based on Mn/H-Ferritin Nanocomplexes 219
Single-domain protein A-engineered magnetic nanoparticles: toward a universal strategy to site-specific labeling of antibodies for targeted detection of tumor cells 215
Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands 214
O6-alkylguanine-DNA transferase (SNAP) as capture module for site-specific covalent bioconjugation of targeting protein on nanoparticles 214
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 213
Orientation-controlled conjugation of haloalkane dehalogenase fused homing peptides to multifunctional nanoparticles for the specific recognition of cancer cells 208
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction 208
Light scattered by model phantom bacteria reveals molecular interactions at their surface 207
Saporin Toxin Delivered by Engineered Colloidal Nanoparticles Is Strongly Effective against Cancer Cells 206
Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases 206
Peptide-nanoparticle ligation mediated by cutinase fusion for the development of cancer cell-targeted nanoconjugates 200
Biotechnological approaches toward nanoparticle biofunctionalization 199
Stem Cell-Mediated Exon Skipping of the Dystrophin Gene by the Bystander Effect 199
Immobilization of carboxypeptidase from Sulfolobus solfataricus on magnetic nanoparticles improves enzyme stability and functionality in organic media 197
Advanced Cell Culture Models Illuminate the Interplay between Mammary Tumor Cells and Activated Fibroblasts 191
Towards ideal magnetofluorescent nanoparticles for bimodal detection of breast-cancer cells 191
Conjugation of gold nanoparticles with multidentate surfactants for enhanced stability and biological properties 189
The synthesis of allolactose from amygdalin 188
Site-Specific Conjugation of ScFvs Antibodies to Nanoparticles by Bioorthogonal Strain-Promoted Alkyne-Nitrone Cycloaddition 188
Antiproliferative effect of ASC-J9 delivered by PLGA nanoparticles against estrogen-dependent breast cancer cells 187
Multi-spot, label-free biodetection at a phantom plastic-water interface 186
Towards a universal method for the stable and clean functionalization of inert perfluoropolymer nanoparticles: exploiting photopolymerizable amphiphilic diacetylenes 185
Magnetofluorescent nanoparticles for bimodal detection of breast cancer cells 184
Gold nanoparticles decorated by clustered multivalent cone-glycocalixarenes actively improve the targeting efficiency toward cancer cells 184
Investigating the structural biofunctionality of antibodies conjugated to magnetic nanoparticles 183
Click Chemistry Immobilization of Antibodies on Polymer Coated Gold Nanoparticles 183
Protein-Assisted One-Pot Synthesis and Biofunctionalization of Spherical Gold Nanoparticles for Selective Targeting of Cancer Cells 182
Femtomolar detection of auto-antibodies by magnetic relaxation nanosensors 181
Development of U11-functionalized gold nanoparticles for selective targeting of urokinase plasminogen activator receptor-positive breast cancer cells 180
Surfactant protein D (SP-D) as a biomarker of SARS-CoV-2 infection 178
Phantom nanoparticles as probes of biomolecular interactions 178
Avidin decorated core-shell nanoparticles for biorecognition studies by elastic light scattering 178
Synthesis of novel carborane-hybrids based on a triazine scaffold for boron neutron capture therapy 178
Synthesis of novel pseudodisaccharides and neoglycoconjugates containing an N-glycosyl carbamate backbone 176
HER2 Expression in Breast Cancer Cells Is Downregulated Upon Active Targeting by Antibody-Engineered Multifunctional Nanoparticles in Mice 175
Heteronanoparticles by Self-Assembly of Ecdysteroid and Doxorubicin Conjugates to Overcome Cancer Resistance 175
Molecular nanoclinics: dream or reality? 174
Totale 28.356
Categoria #
all - tutte 106.414
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.414


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020859 0 0 0 0 0 0 0 0 0 331 341 187
2020/20216.891 247 312 531 590 522 698 578 686 600 780 499 848
2021/20225.546 605 587 601 526 334 352 451 410 317 355 390 618
2022/20235.893 745 1.452 720 619 524 793 127 210 372 102 138 91
2023/20242.895 123 86 161 131 350 624 655 96 172 76 82 339
2024/20254.788 371 601 677 364 633 308 484 298 745 307 0 0
Totale 36.939